Health product recall: APO-BRIMONIDINE-TIMOP weight out of specification
Summary
Health Canada has issued a recall for APO-BRIMONIDINE-TIMOP due to a weight specification issue in lot VK2312. The recall is classified as Type II, indicating a low probability of adverse health consequences. Retailers are instructed to remove the affected product from shelves.
What changed
Health Canada, through Apotex Inc., has initiated a Type II health product recall for APO-BRIMONIDINE-TIMOP (Brimonidine tartrate 0.2% w/v and timolol 0.5% w/v) in lot VK2312. The recall is due to the product's weight being out of specification. This action is being taken to ensure product quality and patient safety, although the risk of adverse health consequences is considered low.
Retailers are directed to remove the affected product from their inventory. Consumers are advised to verify if they possess the affected lot and to consult their healthcare provider before discontinuing use or if they have health concerns. The recalling firm should be contacted for any questions. Health Canada also requests reporting of any related side effects or safety complaints.
What to do next
- Verify if APO-BRIMONIDINE-TIMOP lot VK2312 is in inventory.
- Remove affected product from shelves.
- Report any health product side effects or safety complaints to Health Canada.
Source document (simplified)
Health product recall
APO-BRIMONIDINE-TIMOP: The weight is out of specification in the affected lot.
Brand(s)
Last updated
2026-03-05
Summary
Product APO-BRIMONIDINE-TIMOP Issue Health products - Product safety What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
| --- | --- | --- | --- | --- | --- |
| APO-BRIMONIDINE-TIMOP | APO-BRIMONIDINE-TIMOP | DIN 02375311 | Solution | Brimonidine tartrate 0.2% w/v and timolol 0.5% w/v (as timolol maleate) | VK2312 |
Issue
The weight is out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
2026-03-05
Alert / recall type Health product recall Category Health products - Drugs Companies
Apotex Inc.
380 Elgin Mills Road East,
Richmond Hill, ON
L4C 5H2,
Canada
Published by Health Canada Audience General public Healthcare Industry Recall class Type II Recall date
2026-03-05
Identification number RA-81702
Get notified
Receive emails about new and updated recall and safety alerts.
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Health Canada Recalls & Safety Alerts publishes new changes.